Correlation Between PhaseBio Pharmaceuticals and Advanced Proteome
Can any of the company-specific risk be diversified away by investing in both PhaseBio Pharmaceuticals and Advanced Proteome at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PhaseBio Pharmaceuticals and Advanced Proteome into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PhaseBio Pharmaceuticals and Advanced Proteome Therapeutics, you can compare the effects of market volatilities on PhaseBio Pharmaceuticals and Advanced Proteome and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PhaseBio Pharmaceuticals with a short position of Advanced Proteome. Check out your portfolio center. Please also check ongoing floating volatility patterns of PhaseBio Pharmaceuticals and Advanced Proteome.
Diversification Opportunities for PhaseBio Pharmaceuticals and Advanced Proteome
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between PhaseBio and Advanced is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding PhaseBio Pharmaceuticals and Advanced Proteome Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Advanced Proteome and PhaseBio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PhaseBio Pharmaceuticals are associated (or correlated) with Advanced Proteome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Advanced Proteome has no effect on the direction of PhaseBio Pharmaceuticals i.e., PhaseBio Pharmaceuticals and Advanced Proteome go up and down completely randomly.
Pair Corralation between PhaseBio Pharmaceuticals and Advanced Proteome
Assuming the 90 days horizon PhaseBio Pharmaceuticals is expected to generate 36.14 times more return on investment than Advanced Proteome. However, PhaseBio Pharmaceuticals is 36.14 times more volatile than Advanced Proteome Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Advanced Proteome Therapeutics is currently generating about -0.06 per unit of risk. If you would invest 0.06 in PhaseBio Pharmaceuticals on August 31, 2024 and sell it today you would lose (0.03) from holding PhaseBio Pharmaceuticals or give up 50.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 8.31% |
| Values | Daily Returns |
PhaseBio Pharmaceuticals vs. Advanced Proteome Therapeutics
Performance |
| Timeline |
| PhaseBio Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Advanced Proteome |
PhaseBio Pharmaceuticals and Advanced Proteome Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PhaseBio Pharmaceuticals and Advanced Proteome
The main advantage of trading using opposite PhaseBio Pharmaceuticals and Advanced Proteome positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PhaseBio Pharmaceuticals position performs unexpectedly, Advanced Proteome can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Advanced Proteome will offset losses from the drop in Advanced Proteome's long position.The idea behind PhaseBio Pharmaceuticals and Advanced Proteome Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Advanced Proteome vs. ACG Metals Limited | Advanced Proteome vs. Dave Busters Entertainment | Advanced Proteome vs. GE Vernova LLC | Advanced Proteome vs. NRG Energy |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |